Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 191,948,304
  • Shares Outstanding, K 5,547,639
  • Annual Sales, $ 51,750 M
  • Annual Income, $ 16,273 M
  • 60-Month Beta 0.60
  • Price/Sales 3.60
  • Price/Cash Flow 8.18
  • Price/Book 2.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.71
  • Number of Estimates 3
  • High Estimate 0.81
  • Low Estimate 0.59
  • Prior Year 0.85
  • Growth Rate Est. (year over year) -16.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.88 +26.94%
on 03/23/20
35.77 -1.05%
on 04/09/20
+1.63 (+4.83%)
since 03/09/20
3-Month
27.88 +26.94%
on 03/23/20
40.97 -13.62%
on 01/24/20
-3.50 (-9.00%)
since 01/09/20
52-Week
27.88 +26.94%
on 03/23/20
44.56 -20.58%
on 07/03/19
-7.45 (-17.39%)
since 04/09/19

Most Recent Stories

More News
Watch for Pfizer Inc to Potentially Pullback After Gaining 2.46% Yesterday

Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $34.85 to a high of $35.47. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $35.17...

PFE : 35.39 (+2.28%)
Pfizer Inc Rises 2.46% on Heavy Volume: Watch For Potential Pullback

Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $34.85 to a high of $35.47. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $35.17...

PFE : 35.39 (+2.28%)
Pfizer's Braftovi Combo Gets FDA Nod for Colorectal Cancer

Pfizer (PFE) secures an FDA approval for Braftovi combined with Lilly's Erbitux to treat BRAFV600E-mutant metastatic colorectal cancer in patients who received prior therapy.

PFE : 35.39 (+2.28%)
LLY : 145.73 (-0.34%)
BMY : 58.91 (+1.13%)
ABBV : 79.75 (+1.51%)
J&J (JNJ) Q1 Earnings May Indicate Coronavirus Impact on Pharma

Investor focus is likely to be on the impact of the coronavirus outbreak on J&J's (JNJ) performance when it reports first-quarter results.

JNJ : 141.23 (-1.42%)
PFE : 35.39 (+2.28%)
MRK : 82.49 (+1.07%)
LLY : 145.73 (-0.34%)
Thinking about trading options or stock in Walt Disney, Microsoft, Pfizer, Wynn Resorts, or Exxon Mobil?

InvestorsObserver issues critical PriceWatch Alerts for DIS, MSFT, PFE, WYNN, and XOM.

XOM : 43.13 (-1.64%)
MSFT : 165.14 (+0.01%)
PFE : 35.39 (+2.28%)
DIS : 104.50 (+3.39%)
WYNN : 70.65 (+2.29%)
Pfizer Advances Battle Against COVID-19 on Multiple Fronts

Pfizer Inc. (NYSE: PFE) today announced important advances in the battle against the global COVID-19 pandemic.

PFE : 35.39 (+2.28%)
Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development

BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company"), and Pfizer Inc. (NYSE: PFE) today disclosed additional details of their collaboration to advance candidates from BioNTech's mRNA vaccine program,...

PFE : 35.39 (+2.28%)
FMI Revises Varicella Zoster Infection Treatment Market Forecast, as COVID-19 Pandemic Continues to Expand Quickly

Future Market Insights (FMI) has published a new report on the varicella zoster infection treatment market titled Varicella zoster infection comprises two main types namely varicella chickenpox and herpes...

ABT : 86.04 (+1.28%)
GSK : 38.88 (+2.10%)
NVS : 84.85 (-0.90%)
PFE : 35.39 (+2.28%)
TEVA : 10.16 (+3.25%)
VRX.TO : 30.80 (-3.33%)
Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development

EQNX::TICKER_START (NASDAQ:BNTX),(NYSE:PFE), EQNX::TICKER_END

BNTX : 45.41 (+1.02%)
PFE : 35.39 (+2.28%)
Herpes Labialis Treatment Market Revenue to Decline During Coronavirus Disruption, Stakeholders to Realign Their Growth Strategies

Attributed to rising penetration of generics and innovations in disease treatment, the US$ 869.3 Mn global herpes labialis treatment market is anticipated to expand at a CAGR of 4.6% over 2017-2027, attaining...

GSK : 38.88 (+2.10%)
PFE : 35.39 (+2.28%)
TEVA : 10.16 (+3.25%)
VRX.TO : 30.80 (-3.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade PFE with:

Business Summary

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional...

See More

Key Turning Points

2nd Resistance Point 36.25
1st Resistance Point 35.82
Last Price 35.39
1st Support Level 34.90
2nd Support Level 34.42

See More

52-Week High 44.56
Fibonacci 61.8% 38.19
Fibonacci 50% 36.22
Last Price 35.39
Fibonacci 38.2% 34.25
52-Week Low 27.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar